Merck signs fresh agreement with biotech Nuevolution
This article was originally published in Scrip
Executive Summary
After signing a drug discovery deal back in 2008, Merck & Co and small, privately held biotech Nuevolution have now entered an exclusive licensing agreement for the fruits of their initial partnership.